Page last updated: 2024-08-21

isoxazoles and pyrazinamide

isoxazoles has been researched along with pyrazinamide in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19901 (33.33)18.7374
1990's1 (33.33)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dan, T; Koga, H; Tanaka, H1
Aoki, B; Dan, T; Koga, H; Onuma, E; Sato, H; Tanaka, H1
Boulle, A; Fox, T; Khomo, N; Kock, Y; Leslie, J; Manning, K; Meintjes, G; Mudaly, V; Stewart, A; Tiffin, N; Wasserman, S; Zhao, Y1

Other Studies

3 other study(ies) available for isoxazoles and pyrazinamide

ArticleYear
Mechanism of uricosuric action of AA-193 in DBA/2N mice.
    The Journal of pharmacology and experimental therapeutics, 1990, Volume: 253, Issue:2

    Topics: Animals; Inulin; Isoxazoles; Kidney Tubules, Proximal; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred DBA; Oxazoles; Pyrazinamide; Species Specificity; Uric Acid; Uricosuric Agents

1990
The activity of AA-193, a new uricosuric agent, in animals.
    Advances in experimental medicine and biology, 1989, Volume: 253A

    Topics: Animals; Cebus; Dose-Response Relationship, Drug; Gout Suppressants; Isoxazoles; Male; Metabolic Clearance Rate; Mice; Pyrazinamide; Rats; Rats, Inbred Strains; Species Specificity; Uric Acid; Uricosuric Agents; Urinary Bladder

1989
Improved Treatment Outcomes With Bedaquiline When Substituted for Second-line Injectable Agents in Multidrug-resistant Tuberculosis: A Retrospective Cohort Study.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2019, 04-24, Volume: 68, Issue:9

    Topics: Adult; Antitubercular Agents; Coinfection; Diarylquinolines; Drug Resistance, Multiple, Bacterial; Ethambutol; Ethionamide; Female; HIV; HIV Infections; Humans; Isoniazid; Isoxazoles; Levofloxacin; Male; Mycobacterium tuberculosis; Oxazolidinones; Pyrazinamide; Retrospective Studies; South Africa; Survival Analysis; Treatment Outcome; Tuberculosis, Multidrug-Resistant

2019